Skip to main content
Top
Published in: European Radiology 5/2014

01-05-2014 | Head and Neck

Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg

Authors: Letterio Salvatore Politi, Claudia Godi, Gabriella Cammarata, Alessandro Ambrosi, Antonella Iadanza, Roberto Lanzi, Andrea Falini, Stefania Bianchi Marzoli

Published in: European Radiology | Issue 5/2014

Login to get access

Abstract

Objectives

To compare extraocular muscles (EOMs) T2, post-contrast T1 (T1Gad) signal intensity ratios (SIRs) and normalized-apparent diffusion coefficient (n-ADC) values in patients with thyroid-associated orbitopathy (TAO) at different phases of activity and severity and correlate MRI modifications to clinical evolution during follow-up.

Methods

A total of 74 TAO patients were classified as active or inactive on the basis of the clinical activity score (CAS). Severity of EOM impairment was evaluated by assigning a functional score to each rectus. T2, T1Gad SIRs and n-ADC of EOMs were compared in patients with active inflammation, those with inactive disease and 26 healthy controls, and correlated with clinical scores. MRI parameter variation was correlated with clinical modifications during follow-up.

Results

All MRI parameters in TAO EOMs were significantly higher than in healthy subjects and correlated with muscle dysfunction and CAS. EOMs of active patients showed higher T2 and T1Gad SIRs than those with inactive disease. The T2 SIR and n-ADC of normally functioning TAO EOMs were higher than those of healthy controls. SIRs decreased in clinically improved and clinically stable EOMs after therapy.

Conclusions

T2 SIR, T1Gad SIR and n-ADC are objective measures of activity and severity of EOMs in TAO patients. MRI shows clinically silent muscle involvement and modifications.

Key Points

MRI and DWI measures are objective, quantitative parameters of TAO activity and severity

MRI and DWI measures significantly correlate with clinical scores in TAO patients

MRI and DWI can identify clinically silent inflammation of deep orbital structures

MRI and DWI can depict subclinical modifications during follow-up

MRI and DWI may aid clinicians in choosing the most appropriate treatment

Literature
  1. Dickinson AJ, Perros P (2001) Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment. Clin Endocrinol (Oxf) 55:283–303View Article
  2. Bartalena L, Tanda ML (2009) Graves' ophthalmopathy. N Engl J Med 360:994–1001PubMedView Article
  3. Parmar H, Ibrahim M (2008) Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy. Neuroimaging Clin N Am 18:527–536PubMedView Article
  4. El-Kaissi S, Frauman AG, Wall JR (2004) Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management. Intern Med J 34:482–491PubMedView Article
  5. Carl A, Pedersen IB, Knudsen N et al (2011) Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 164:801–809View Article
  6. Abraham-Nordling M, Bystrom K, Torring O et al (2011) Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 165:899–905PubMedView Article
  7. Eckstein A, Schittkowski M, Esser J (2012) Surgical treatment of Graves' ophthalmopathy. Best Pract Res Clin Endocrinol Metab 26:339–358PubMedView Article
  8. Soeters M, van Zeijl C, Boelen A et al (2011) Optimal management of Graves orbitopathy: a multidisciplinary approach. Neth J Med 69:302–308PubMed
  9. Boboridis K, Bunce C (2011) Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev CD007630
  10. Mourits M, Koornneef L, Wiersinga W, Prummel M, Berghout A, van der Gaag R (1989) Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach. Br J Ophthalmol 73:639–644PubMed CentralPubMedView Article
  11. Hosten N, Sander B, Cordes M, Schubert CJ, Schorner W, Felix R (1989) Graves ophthalmopathy: MR imaging of the orbits. Radiology 172:759–762PubMed
  12. Sillaire I (2003) Graves' ophthalmopathy: usefulness of T2 weighted muscle signal intensity. J Radiol 84:139–142PubMed
  13. Prummel MF, Gerding MN, Zonneveld FW, Wiersinga WM (2001) The usefulness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy. Clin Endocrinol 54:205–209View Article
  14. Taoka T, Iwasaki S, Uchida H (2000) Enhancement pattern of normal extraocular muscles in dynamic contrast-enhancement MR imaging with suppression. Acta Radiol 41:211–216PubMedView Article
  15. Taoka T (2005) Evaluation of extraocular muscles using dynamic contrast enhanced MRI in patients with chronic thyroid orbitopathy. J Comput Assist Tomogr 29:115–120PubMedView Article
  16. Cakirer S (2004) Evaluation of extraocular muscles in the edematous phase of Graves ophthalmopathy on contrast-enhanced fat-suppressed magnetic resonance imaging. J Comput Assist Tomogr 28:80–86PubMedView Article
  17. Sepahdari AR, Aakalu V, Setabutr P, Shiehmorteza M, Naheedy JH, Mafee MF (2010) Indeterminate orbital masses at MR imaging. Radiology 256:554–564PubMedView Article
  18. Politi LS, Forghani R, Godi C et al (2010) Ocular adnexal lymphoma: diffusion-weighted MR Imaging for differential diagnosis and therapeutic monitoring. Radiology 256:565–574PubMedView Article
  19. Razek A, Elkhamary S, Mousa A (2011) Differentiation between benign and malignant orbital tumors at 3-T diffusion MR-imaging. Neuroradiology 53:517–522PubMedView Article
  20. Sepahdari AR, Kapur R, Aakalu VK, Villablanca JP, Mafee MF (2012) Diffusion-weighted imaging of malignant ocular masses: initial results and directions for further study. Am J Neuroradiol 33:314–319PubMedView Article
  21. Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A (2012) Incidence and clinical presentation of moderate to severe Graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab 97:2325–2332PubMed CentralPubMedView Article
  22. Kirsch E, Kaim AH, Oliveira MGD, Gv A (2010) Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy-a pilot study at 1.5 T. Neuroradiology 52:91–97PubMedView Article
  23. Gonçalves AC, Silva LN, Gebrim EM, Monteiro ML (2012) Quantification of orbital apex crowding for screening of dysthyroid optic neuropathy using multidetector CT. Am J Neuroradiol 33:1602–1607PubMedView Article
  24. Müller-Forell W, Kahaly GJ (2012) Neuroimaging of Graves' orbitopathy. Best Pract Res Clin Endocrinol Metab 26:259–271PubMedView Article
  25. Bijlsma WR (2006) Radiologic measurement of extraocular muscle volumes in patients with Graves' orbitopathy: a review and guideline. Orbit 25:83–91PubMedView Article
Metadata
Title
Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg
Authors
Letterio Salvatore Politi
Claudia Godi
Gabriella Cammarata
Alessandro Ambrosi
Antonella Iadanza
Roberto Lanzi
Andrea Falini
Stefania Bianchi Marzoli
Publication date
01-05-2014
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 5/2014
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-014-3103-3

Other articles of this Issue 5/2014

European Radiology 5/2014 Go to the issue